. 2019 May 9;14(5):e0216715. doi: 10.1371/journal.pone.0216715

Table 1. Demographic and clinical parameters for the patients who received antifungal therapy.

	Antifungal therapy n. 221
Age (years), median (range), +/- SD	61 (18–85) ± 15
Male/female	129/92
Hematological malignancies, n (%)^*
Lymphoma	48 (22)
Acute myeloid leukemia	104 (47)
Acute lymphoblastic leukemia Chronic lymphocytic leukemia	20 (9) 14 (6)
Multiple myeloma Other oncohematological diseases	10 (5) 25 (11)
Neutropenia, n (%)^* (absolute neutrophil count<0.5x10⁹/L)	177 (80)
Proven IFI, n (%)^*	22 (10)
Probable IFI, n (%)^*	61 (28)
Possible IFI, n (%)^*	81 (37)
Not otherwise classifiable, n (%)^*	57 (26)

* Percentage (%) was calculated on total number of AFTs (n. 221), approximated to the nearest whole number.